Advertisement

Preoperative Coronary Intervention Before Orthotopic Liver Transplantation (from a Review of Literature)

Published:October 11, 2022DOI:https://doi.org/10.1016/j.amjcard.2022.09.014
      There is significant morbidity and mortality associated with the presence of coronary artery disease (CAD) in the setting of orthotopic liver transplantation in patients with end-stage liver disease. The prevalence of CAD in this cohort is similar to, if not higher, than the general population. Several studies show improved survival rates for patients with obstructive CAD who undergo percutaneous coronary intervention (PCI) and support a low threshold for PCI in these patients. However, a few studies have failed to show improved mortality associated with PCI in this cohort. This review hopes to highlight the current recommendations regarding the assessment of CAD in patients with end-stage liver disease who are orthotopic liver transplantation candidates and describe the outcomes of PCIs.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Diedrich DA
        • Findlay JY
        • Harrison BA
        • Rosen CB
        Influence of coronary artery disease on outcomes after liver transplantation.
        Transplant Proc. 2008; 40: 3554-3557
        • Plotkin JS
        • Scott VL
        • Pinna A
        • Dobsch BP
        • De Wolf AM
        • Kang Y.
        Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation.
        Liver Transpl Surg. 1996; 2: 426-430
        • Carey WD
        • Dumot JA
        • Pimentel RR
        • Barnes DS
        • Hobbs RE
        • Henderson JM
        • Vogt DP
        • Mayes JT
        • Westveer MK
        • Easley KA.
        The prevalence of coronary artery disease in liver transplant candidates over age 50.
        Transplantation. 1995; 59: 859-864
        • Centers for Disease Control and Prevention (CDC)
        Prevalence of coronary heart disease–United States, 2006-2010.
        MMWR Morb Mortal Wkly Rep. 2011; 60: 1377-1381
        • Patel SS
        • Lin FP
        • Rodriguez VA
        • Bhati C
        • John BV
        • Pence T
        • Siddiqui MB
        • Sima AP
        • Abbate A
        • Reichman T
        • Siddiqui MS.
        The relationship between coronary artery disease and cardiovascular events early after liver transplantation.
        Liver Int. 2019; 39: 1363-1371
        • Alexander S
        • Teshome M
        • Patel H
        • Chan EY
        • Doukky R.
        The diagnostic and prognostic utility of risk factors defined by the AHA/ACCF on the evaluation of cardiac disease in liver transplantation candidates.
        BMC Cardiovasc Disord. 2019; 19: 102
        • Martin P
        • DiMartini A
        • Feng S
        • Brown Jr, R
        • Fallon M.
        Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.
        Hepatology. 2014; 59: 1144-1165
        • Kim WR
        • Lake JR
        • Smith JM
        • Schladt DP
        • Skeans MA
        • Harper AM
        • Wainright JL
        • Snyder JJ
        • Israni AK
        • Kasiske BL.
        OPTN/SRTR 2016 annual data report: liver.
        Am J Transplant. 2018; 18: 172-253
        • Steadman RH.
        Anesthesia for liver transplant surgery.
        Anesthesiol Clin North America. 2004; 22: 687-711
        • Koshy AN
        • Nerlekar N
        • Gow PJ
        • Lim R
        • Smith G
        • Galea M
        • Rodrigues TS
        • Lim HS
        • Teh AW
        • Farouque O.
        A prospective natural history study of coronary atherosclerosis following liver transplantation.
        Atherosclerosis. 2022; 344: 40-48
        • Keeffe BG
        • Valantine H
        • Keeffe EB.
        Detection and treatment of coronary artery disease in liver transplant candidates.
        Liver Transpl. 2001; 7: 755-761
        • Aghaulor B
        • VanWagner LB.
        Cardiac and pulmonary vascular risk stratification in liver transplantation.
        Clin Liver Dis. 2021; 25: 157-177
        • Aydinalp A
        • Atar I
        • Bal U
        • Aktas A
        • Ertan C
        • Atar A
        • Yildirir A
        • Ozin B
        • Muderrisoglu H
        • Haberal M.
        Determinants of coronary artery disease in liver transplant candidates.
        Exp Clin Transplant. 2010; 8: 142-145
        • Kadayifci A
        • Tan V
        • Ursell PC
        • Merriman RB
        • Bass NM.
        Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies.
        J Hepatol. 2008; 49: 595-599
        • Rachwan RJ
        • Kutkut I
        • Timsina LR
        • Bou Chaaya RG
        • El-Am EA
        • Sabra M
        • Mshelbwala FS
        • Rahal MA
        • Lacerda MA
        • Kubal C A
        • Fridell JA
        • Ghabril MS
        • Bourdillon PD
        • Mangus RS
        CAD-LT score effectively predicts risk of significant coronary artery disease in liver transplant candidates.
        J Hepatol. 2021; 75: 142-149
        • Bonou M
        • Mavrogeni S
        • Kapelios CJ
        • Skouloudi M
        • Aggeli C
        • Cholongitas E
        • Papatheodoridis G
        • Barbetseas J.
        Preoperative evaluation of coronary artery disease in liver transplant candidates: many unanswered questions in clinical practice.
        Diagnostics (Basel). 2021; 11: 75
        • Nguyen P
        • Plotkin J
        • Fishbein TM
        • Laurin JM
        • Satoskar R
        • Shetty K
        • Taylor AJ.
        Dobutamine stress echocardiography in patients undergoing orthotopic liver transplantation: a pooled analysis of accuracy, perioperative and long term cardiovascular prognosis.
        Int J Cardiovasc Imaging. 2013; 29: 1741-1748
        • Soldera J
        • Camazzola F
        • Rodríguez S
        • Brandão A.
        Dobutamine stress echocardiography, myocardial perfusion scintigraphy, invasive coronary angiography, and post-liver transplantation events: systematic review and meta-analysis.
        Clin Transplant. 2018; 32: e13222
        • Ehtisham J
        • Altieri M
        • Salamé E
        • Saloux E
        • Ollivier I
        • Hamon M.
        Coronary artery disease in orthotopic liver transplantation: pretransplant assessment and management.
        Liver Transpl. 2010; 16: 550-557
        • Tiwari N
        • Margapuri J
        • Katamreddy A
        • Jubbal S
        • Madan N.
        Diagnostic accuracy of cardiac testing for coronary artery disease in potential liver transplant recipients: a systematic review and meta-analysis.
        Int J Cardiol Heart Vasc. 2021; 32100714
        • Zorzi A
        • Brunetti G
        • Cardaioli F
        • D'Arcangelo F
        • Fabris T
        • Gambato M
        • Iliceto S
        • Martini A
        • Mattesi G
        • Peluso C
        • Polacco M
        • Sartori C
        • Lorenzoni G
        • Feltracco P
        • Angeli P
        • Burra P
        • Cillo U
        • Pontisso P
        Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation.
        Int J Cardiol. 2021; 339: 219-224
        • Kong HY
        • Zhao X
        • Wang KR.
        Intraoperative management and early post-operative outcomes of patients with coronary artery disease who underwent orthotopic liver transplantation.
        Hepatobiliary Pancreat Dis Int. 2020; 19: 12-16
        • Kemmer N
        • Case J
        • Chandna S
        • Neff GW.
        The role of coronary calcium score in the risk assessment of liver transplant candidates.
        Transplant Proc. 2014; 46: 230-233
        • Choi JM
        • Kong YG
        • Kang JW
        • Kim YK.
        Coronary computed tomography angiography in combination with coronary artery calcium scoring for the preoperative cardiac evaluation of liver transplant recipients.
        BioMed Res Int. 2017; 4081525
        • Kim DH
        • Kim YK
        • Ha TY
        • Hwang S
        • Kim W
        • Koo HJ
        • Yang DH
        • Kang JW
        • Lee SG.
        Prognostic value of computed tomographic coronary angiography for long-term major adverse cardiac events after liver transplantation.
        J Clin Med. 2021; 10: 3132
        • Steinkohl F
        • Barbieri F
        • Senoner T
        • Strobl S
        • Finkenstedt A
        • Plank F
        • Langer C
        • Beyer C
        • Birkl K
        • Widmann G
        • Zoller H
        • Dichtl W
        • Friedrich G
        • Tilg H
        • Feuchtner G.
        Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study.
        Eur Radiol. 2021; 31: 494-503
        • Jodocy D
        • Abbrederis S
        • Graziadei IW
        • Vogel W
        • Pachinger O
        • Feuchtner GM
        • Jaschke W
        • Friedrich G.
        Coronary computer tomographic angiography for preoperative risk stratification in patients undergoing liver transplantation.
        Eur J Radiol. 2012; 81: 2260-2264
        • Azarbal B
        • Poommipanit P
        • Arbit B
        • Hage A
        • Patel J
        • Kittleson M
        • Kar S
        • Kaldas FM
        • Busuttil RW.
        Feasibility and safety of percutaneous coronary intervention in patients with end-stage liver disease referred for liver transplantation.
        Liver Transpl. 2011; 17: 809-813
        • Kirkbride RR
        • Larkin E
        • Tuttle MK
        • Nicholson MD
        • Jiang BG
        • Liubauskas R
        • Matos JD
        • Gavin M
        • Litmanovich DE.
        Quality and diagnostic performance of coronary computed tomography angiogram (CCTA): A comparison between pre-liver and pre-kidney transplant patients.
        Eur J Radiol. 2021; 143109886
      1. Schuessler M, Saner F, Al-Rashid F, Schlosser T. Diagnostic accuracy of coronary computed tomography angiography-derived fractional flow reserve (CT-FFR) in patients before liver transplantation using CT-FFR machine learning algorithm [published online June 22, 2022]. Eur Radiol doi:10.1007/s00330-022-08921-1.

        • Huded CP
        • Blair JE
        • Sweis RN
        • Flaherty JD.
        Transradial cardiac catheterization in liver transplant candidates.
        Am J Cardiol. 2014; 113: 1634-1638
        • VanWagner LB
        • Harinstein ME
        • Runo JR
        • Darling C
        • Serper M
        • Hall S
        • Kobashigawa JA
        • Hammel LL.
        Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: an evaluation of the evidence and consensus recommendations.
        Am J Transplant. 2018; 18: 30-42
        • Ostojic Z
        • Ostojic A
        • Bulum J
        • Mrzljak A.
        Safety and efficacy of dual antiplatelet therapy after percutaneous coronary interventions in patients with end-stage liver disease.
        World J Cardiol. 2021; 13: 599-607
        • Axelrod D
        • Koffron A
        • Dewolf A
        • Baker A
        • Fryer J
        • Baker T
        • Frederiksen J
        • Horvath K
        • Abecassis M.
        Safety and efficacy of combined orthotopic liver transplantation and coronary artery bypass grafting.
        Liver Transpl. 2004; 10: 1386-1390
        • Juneja R
        • Kumar A
        • Ranjan R
        • Hemantlal PM
        • Mehta Y
        • Wasir H
        • Vohra V
        • Trehan N.
        Combined off pump coronary artery bypass graft and liver transplant.
        Ann Card Anaesth. 2021; 24: 197-202
        • Jacobs E
        • Singh V
        • Damluji A
        • Shah NR
        • Warsch JL
        • Ghanta R
        • Martin P
        • Alfonso CE
        • Martinez CA
        • Moscucci M
        • Cohen MG.
        Safety of transradial cardiac catheterization in patients with end-stage liver disease.
        Catheter Cardiovasc Interv. 2014; 83: 360-366
        • Lee MS.
        Diagnostic yield of coronary angiography in asymptomatic orthotopic liver transplantation candidates.
        Cardiovasc Revasc Med. 2022; 35: 59-63
        • West BH
        • Low CG
        • Bista BB
        • Yang EH
        • Vorobiof G
        • Busuttil RW
        • Budoff MJ
        • Elashoff D
        • Tobis JM
        • Honda HM.
        Significance of coronary artery calcium found on non-electrocardiogram-gated computed tomography during preoperative evaluation for liver transplant.
        Am J Cardiol. 2019; 124: 278-284
        • Satapathy SK
        • Vanatta JM
        • Helmick RA
        • Flowers A
        • Kedia SK
        • Jiang Y
        • Ali B
        • Eason J
        • Nair SP
        • Ibebuogu UN.
        Outcome of liver transplant recipients with revascularized coronary artery disease: a comparative analysis with and without cardiovascular risk factors.
        Transplantation. 2017; 101: 793-803
        • Maddur H
        • Bourdillon PD
        • Liangpunsakul S
        • Joseph Tector A
        • Fridell JA
        • Ghabril M
        • Lacerda MA
        • Bourdillon C
        • Shen C
        • Kwo PY
        Role of cardiac catheterization and percutaneous coronary intervention in the preoperative assessment and management of patients before orthotopic liver transplantation.
        Liver Transpl. 2014; 20: 664-672
        • Kutkut I
        • Rachwan RJ
        • Timsina LR
        • Ghabril MS
        • Lacerda MA
        • Kubal CA
        • Bourdillon PD
        • Mangus RS.
        Pre-liver transplant cardiac catheterization is associated with low rate of myocardial infarction and cardiac mortality.
        Hepatology. 2020; 72: 240-256
        • Singh IM
        • Antoun PS
        • Shoemaker TJ
        • Terry C
        • Kwo PY
        • Tector JA
        • Breall JA
        • Sadanandan S.
        Cardiac catheterization as a strategy for pre-operative risk stratification in patients undergoing liver transplantation.
        Circulation. 2008; 118 (S_903–S_904)
        • Feng K
        • Gupta V
        • Terrazas E
        • Yeghiazarians Y
        • Ports T
        • Gregoratos G
        • Tavakol M
        • Roberts JP
        • Boyle A.
        Trans-radial versus trans-femoral access in patients with end-stage liver disease undergoing cardiac catheterization.
        Am J Cardiovasc Dis. 2014; 4: 133-139
        • Pillarisetti J
        • Patel P
        • Duthuluru S
        • Roberts J
        • Chen W
        • Genton R
        • Wiley M
        • Candipan R
        • Tadros P
        • Gupta K.
        Cardiac catheterization in patients with end-stage liver disease: safety and outcomes.
        Catheter Cardiovasc Interv. 2011; 77: 45-48
        • MacDonald LA
        • Beohar N
        • Wang NC
        • Nee L
        • Chandwaney R
        • Ricciardi MJ
        • Benzuly KH
        • Meyers SN
        • Gheorghiada M
        • Davidson CJ.
        A comparison of arterial closure devices to manual compression in liver transplantation candidates undergoing coronary angiography.
        J Invasive Cardiol. 2003; 15: 68-70
        • Mahmoud AM
        • Elgendy IY
        • Choi CY
        • Bavry AA.
        Risk of bleeding in end-stage liver disease patients undergoing cardiac catheterization.
        Tex Heart Inst J. 2015; 42: 414-418
        • Kirtane AJ
        • Stoler R
        • Feldman R
        • Neumann FJ
        • Boutis L
        • Tahirkheli N
        • Toelg R
        • Othman I
        • Stein B
        • Choi JW
        • Windecker S
        • Yeh RW
        • Dauerman HL
        • Price MJ
        • Underwood P
        • Allocco D
        • Meredith I
        • Kereiakes DJ.
        Primary results of the EVOLVE Short DAPT Study: evaluation of 3-month dual antiplatelet therapy in high bleeding risk patients treated with a bioabsorbable polymer-coated everolimus-eluting stent.
        Circ Cardiovasc Interv. 2021; 14e010144
        • Scheller B
        • Rissanen TT
        • Farah A
        • Ohlow MA
        • Mangner N
        • Wöhrle J
        • Möbius-Winkler S
        • Weilenmann D
        • Leibundgut G
        • Cuculi F
        • Gilgen N
        • Coslovsky M
        • Mahfoud F
        • Jeger RV
        BASKET-SMALL 2 Investigators. Drug-coated balloon for small coronary artery disease in patients with and without high-bleeding risk in the BASKET-SMALL 2 trial.
        Circ Cardiovasc Interv. 2022; 15e011569